# Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis

> **NCT00486317** · PHASE1 · COMPLETED · sponsor: **Nordic Bioscience A/S**

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Oral salmon calcitonin, salmon calcitonin nasal spray

## Key facts

- **NCT ID:** NCT00486317
- **Lead sponsor:** Nordic Bioscience A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486317, "Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00486317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*